Effect of Maraviroc on HIV Disease Progression-Related Biomarkers

The potential effect of blocking the CCR5 receptor on HIV disease progression biomarkers is not well understood. We showed that an 8-day maraviroc (MVC) monotherapy clinical test (MCT) can be used in selecting patients to receive MVC-containing combined antiretroviral therapy (cART). Using this MCT...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Romero-Sánchez, M. Concepción, Machmach, Kawthar, Gonzalez-Serna, Alejandro, Genebat, Miguel, Pulido, Ildefonso, García-García, María, Álvarez-Ríos, Ana Isabel, Ferrando-Martinez, Sara, Ruiz-Mateos, Ezequiel, Leal, Manuel
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2012
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486555/
https://ncbi.nlm.nih.gov/pubmed/22948867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01406-12
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki